Metropolis Healthcare Limited (BOM:542650)

Market Cap	100.96B +12.5%
Revenue (ttm)	15.66B +18.9%
Net Income	1.68B +10.5%
EPS	32.39 +9.5%
Shares Out	n/a
PE Ratio	60.00
Forward PE	42.08
Dividend	4.00 (0.20%)
Ex-Dividend Date	Nov 11, 2025

Volume	793
Average Volume	2,784
Open	1,992.20
Previous Close	1,995.95
Day's Range	1,974.15 - 2,005.00
52-Week Range	1,383.70 - 2,259.30
Beta	n/a
RSI	52.70
Earnings Date	Feb 4, 2026

About Metropolis Healthcare

Metropolis Healthcare Limited, together with its subsidiaries, provides pathology and related healthcare services in India, Africa, South Asia, the Middle East, and internationally. The company offers routine and semi-specialised pathology tests; advanced diagnostics, including genetic, molecular, and cytogenetic testing; preventive healthcare packages and corporate wellness screening; and clinical trial research, hospital lab management, and home collection services, as well as profiles, blood tests, and soft radiology services. It also provid...

• Industry: Medical Laboratories
• Founded: 1980
• Employees: 4,823
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 542650

Financial Performance

In fiscal year 2025, Metropolis Healthcare's revenue was 13.31 billion, an increase of 10.23% compared to the previous year's 12.08 billion. Earnings were 1.45 billion, an increase of 13.42%.